Comtech Telecommunications Corp. engages in the design, development, production, and marketing of products, systems, and services for advanced communications solutions in the United States and internationally. It operates in three segments: Telecommunications Transmission, Mobile Data Communications, and RF Microwave Amplifiers. The Telecommunications Transmission segment provides satellite earth station equipment and systems, over-the-horizon microwave systems, and forward error correction technology, which are used in various commercial and government applications, including backhaul of wireless and cellular traffic, broadcasting (including HDTV), IP-based communications traffic, long distance telephony, and secure defense applications. The Mobile Data Communications segment provides mobile satellite transceivers, and computers and satellite earth station network gateways and associated installation, training, and maintenance services; supplies and operates satellite packet data networks, including arranging and providing satellite capacity; and offers microsatellites and related components. The RF Microwave Amplifiers segment designs, develops, manufactures, and markets satellite earth station traveling wave tube amplifiers (TWTA) and broadband amplifiers. Its amplifiers are used in broadcast and broadband satellite communication; defense applications, such as telecommunications systems and electronic warfare systems; and commercial applications comprising oncology treatment systems, as well as to amplify signals carrying voice, video, or data for air-to-satellite-to-ground communications. The company serves satellite systems integrators, wireless and other communication service providers, broadcasters, defense contractors, military, governments, and oil companies. Comtech markets its products through independent representatives and value-added resellers. The company was founded in 1967 and is headquartered in Melville, New York.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
New Capital Infusion. Last night, after the market closed, Comtech Telecommunications announced a new $40 million capital infusion from the current holders of Comtech’s convertible preferred and subordinated debt, or White Hat Capital and Magnetar Financial. The new capital infusion is made on the same terms and conditions as the prior subordinated debt investment.
Uses. Of the $40 million infusion, $27.3 million is being used to prepay the senior secured term loan and $3.2 million to reduce the revolving credit facility, with a waiver of the prepayment penalties that would have been owed in accordance with the terms of the credit agreement.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Key Points: – OPEC+ surprises market with planned April output increase of 138,000 barrels per day – US imposes new tariffs on Canada, Mexico, and China, triggering potential trade tensions – Micro-cap energy stocks face potential volatility and consolidation opportunities
The global oil market is experiencing a pivotal moment that demands close scrutiny from energy sector investors. OPEC+ has recently confirmed a planned April output increase of 138,000 barrels per day, a decision that has immediately rippled through global energy markets. The financial implications are significant: Brent futures dropped 1.45% to $70.58 per barrel, while U.S. West Texas Intermediate (WTI) crude fell 1.07% to $67.64, signaling a complex and potentially challenging investment landscape.
The current market dynamics are further complicated by a series of aggressive trade policies implemented by the U.S. administration. New tariffs of 25% on imports from Canada and Mexico, coupled with increased Chinese import tariffs from 10% to 20%, are creating a multilayered challenge for energy companies across the value chain. These policy shifts are particularly consequential for smaller energy firms that may lack the financial buffers of larger, more established corporations.
For investors focusing on small and micro-cap energy stocks, the current market presents a nuanced investment environment. The compressed profit margins resulting from these market conditions are likely to accelerate sector consolidation. Companies with robust balance sheets, operational efficiency, and strategic adaptability will be best positioned to weather this volatility.
Commodity market experts provide critical insights into these trends. Darren Lim from Phillip Nova emphasizes that the current market is being driven by a combination of OPEC+ output decisions and new tariff implementations. Goldman Sachs analysts offer additional perspective, noting that Russia’s oil flows remain more constrained by production targets than existing sanctions, with potential downside risks to oil price forecasts.
The geopolitical landscape adds another layer of complexity to the investment calculus. President Trump’s recent pause in Ukraine military aid introduces additional uncertainty that could potentially reshape global oil market dynamics and existing sanctions frameworks. This geopolitical tension creates an additional variable for investors to consider when evaluating energy sector investments.
Investors in small and micro-cap energy stocks should focus on several key strategic considerations:
Fundamental Analysis: A deep dive into individual company financials is crucial. Look beyond surface-level metrics to understand each company’s true operational efficiency, debt levels, and ability to adapt to market fluctuations.
Geographical Diversification: Companies with operations across multiple regions may be better positioned to mitigate risks associated with localized economic or political challenges.
Technological Innovation: Energy firms investing in efficient extraction technologies and exploring alternative energy solutions may demonstrate greater long-term resilience.
Cost Management: In a volatile market, companies that can maintain lean operations and control production costs will have a significant competitive advantage.
While the current market presents significant challenges, it simultaneously creates opportunities for strategic investors. The potential for industry consolidation means that well-positioned companies could emerge as attractive acquisition targets or potential market leaders.
Market indicators suggest that volatility in the energy sector is likely to continue. Successful investment strategies will require a disciplined approach, continuous research, and the ability to adapt quickly to changing market conditions.
Investors should maintain a balanced perspective, recognizing that short-term market fluctuations do not necessarily indicate long-term sector performance. Careful analysis, diversification, and a forward-looking investment approach will be key to navigating these complex market dynamics.
Verb Technology Company, Inc. (Nasdaq: VERB) has announced the acquisition of LyveCom, an AI-driven video commerce platform, in a move that positions its MARKET.live platform as one of the most advanced AI-powered social shopping solutions in the industry. The transaction, which is subject to standard conditions including an audit of LyveCom’s financial statements, is expected to close within 60 days. However, Phase 1 of the integration has already been completed, with the newly updated MARKET.live launching today.
The acquisition brings AI-powered technology that enables brands and merchants to deliver an omnichannel livestream shopping experience. This allows businesses to engage customers not just on the MARKET.live platform, but also across their own websites, mobile apps, and social media platforms. With AI-driven video content automation and personalized shopping experiences, the new capabilities streamline content production while expanding reach. LyveCom’s proprietary technology also allows livestreams and shoppable videos to be embedded directly onto merchant websites without affecting site speed. At the same time, content from TikTok, Instagram, and YouTube can be aggregated and repurposed into interactive shopping experiences, enhancing engagement without the need for constant content creation.
The newly enhanced MARKET.live introduces several industry-changing innovations, including one-click simulcasting that allows brands to broadcast live shopping events across multiple platforms such as TikTok Shop, Shopify’s Shop App, and their own e-commerce websites. AI-powered tools will automate video content creation, while frictionless self-serve onboarding makes it easier for millions of Shopify merchants to integrate live and shoppable video in just three clicks. Strategic partnerships with Tapcart, Klaviyo, and Recharge will further expand MARKET.live’s reach in mobile commerce and direct-to-consumer brands. Additionally, an advanced analytics hub will provide real-time insights into shopper behavior, helping merchants refine their strategies and drive conversions.
The acquisition marks a major step toward establishing VERB’s MARKET.live as a leader in livestream and AI-powered social commerce. The platform’s integration with LyveCom’s AI solutions will enhance video content personalization, automate merchandising strategies, and improve conversion rates through AI-powered predictive analytics. The company also plans to launch AI avatar live shopping hosts, which will engage audiences in real time with near-human realism.
According to a report from The Business Research Company, the global social commerce industry is projected to surpass $1.29 trillion by 2028, growing at a CAGR of 13.7%. VERB’s latest move signals its intent to dominate this rapidly expanding space by setting a new standard for AI-powered interactive video commerce. CEO Rory J. Cutaia reinforced the company’s commitment to innovation, stating that the acquisition ensures MARKET.live will bridge brands, marketplaces, and social platforms in a way that enhances engagement and drives sales.
With the integration of LyveCom’s technology, MARKET.live is now positioned as the go-to platform for brands looking to future-proof their business with AI-powered video commerce. As the industry shifts toward interactive shopping experiences, VERB’s strategic expansion underscores its ambition to lead the next evolution of social commerce.
Key Points: – Taiwan Semiconductor Manufacturing Co. (TSMC) plans to invest $100 billion in US chip plants over the next four years. – The investment aligns with efforts to establish the US as a leader in artificial intelligence and semiconductor production. – The announcement follows US tariffs on semiconductor imports and ongoing efforts to reduce reliance on foreign chip manufacturing.
Taiwan Semiconductor Manufacturing Company (TSMC) is preparing to make a historic $100 billion investment in US chip manufacturing, a move expected to bolster America’s position in the global semiconductor race. President Donald Trump is set to formally announce the initiative, which aims to expand domestic production capacity over the next four years.
The investment will fund multiple new semiconductor fabrication plants, reinforcing efforts to establish the United States as a key hub for artificial intelligence and high-performance computing. This move is seen as a major step in reducing US dependence on foreign chip suppliers, particularly amid growing geopolitical tensions that have raised concerns over supply chain vulnerabilities.
TSMC, the world’s largest contract chipmaker, plays a crucial role in supplying semiconductors to major technology firms such as Nvidia and Apple, both of which heavily rely on cutting-edge chips for artificial intelligence applications. The company has already established a presence in the US with its Arizona-based facilities, where it committed an initial $12 billion in 2020. Since then, its investment in the region has swelled to approximately $65 billion, with plans for a third factory already in motion.
The additional $100 billion investment signals a broader commitment to US-based production, which could help mitigate risks associated with global supply chain disruptions. This initiative aligns with the Trump administration’s strategy to strengthen domestic manufacturing and reduce reliance on imports, particularly from Asia.
President Trump has long accused Taiwan of undercutting US chip manufacturing, advocating for tariffs on semiconductor imports as part of his broader trade policy. However, the latest investment from TSMC could help reshape this dynamic by bringing production closer to home, potentially easing tensions while reinforcing economic ties between the US and Taiwan.
Industry experts view this investment as a significant step toward securing US semiconductor supply chains. The recent CHIPS and Science Act, which provides funding to semiconductor companies expanding in the US, has played a role in attracting further investment from industry leaders. In January, TSMC’s Chief Financial Officer, Wendell Huang, expressed confidence that the US government would continue supporting the company’s expansion efforts.
While TSMC’s massive investment will primarily benefit large-scale semiconductor production, smaller cap chip manufacturers may experience mixed effects. On one hand, increased competition from a well-funded industry giant could challenge their market position. However, these companies may also benefit from enhanced supply chain infrastructure, new partnership opportunities, and greater government incentives aimed at bolstering domestic production.
For investors, this development could signal a bullish outlook for the semiconductor sector. Larger players like Nvidia, Intel, and AMD may see increased demand for domestically produced chips, while smaller firms could attract interest based on their role in supporting new manufacturing initiatives. Market analysts will be watching closely to assess which companies stand to gain the most from this significant shift in semiconductor production.
The expansion of US-based semiconductor manufacturing is expected to create thousands of high-skilled jobs while positioning the country as a leader in AI-driven innovation. Analysts believe the move will help stabilize chip supply and reduce costs for American companies reliant on advanced semiconductors.
With formal announcements expected in the coming days, industry stakeholders and policymakers will closely watch how this investment unfolds. The next steps will likely involve site selection, workforce training initiatives, and government incentives to ensure the success of these new facilities.
As TSMC deepens its US footprint, the semiconductor industry braces for a transformative shift that could redefine global supply chains for years to come.
OVERLAND PARK, Kan.–(BUSINESS WIRE)– SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced that the Company closed and received the proceeds from the $350 million strategic investment on February 28, 2025. The Company originally announced a binding agreement on the transaction with funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners on February 10th.
The Company used $260 million of proceeds to pay down its outstanding term loan. The Company now has more than $100 million of available liquidity as it continues to focus on its industry-leading insurance distribution businesses and rapidly expanding healthcare services business.
With the completion of this transaction, SelectQuote also appointed Chris Wolfe of Bain Capital Insurance and Srdjan Vukovic of Newlight Partners to the Board of Directors, each bringing over 20 years of investing and healthcare sector experience to the Company.
Founded in 1985, SelectQuote (NYSE: SLQT) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care.
With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select which proactively connects consumers with a wide breadth of healthcare services supporting their needs.
GROSSE POINTE FARMS, Mich., March 03, 2025 (GLOBE NEWSWIRE) — Saga Communications, Inc. (Nasdaq: SGA) announced today that it will release its 4th Quarter and Year End 2024 results at 9:00 a.m. EST on Tuesday, March 11, 2025. The company will be holding a conference call on the same date at 11:00 a.m. EST. The dial-in numbers are as follows:
Domestic and International Dial-in Number: (973) 528-0008 Conference Entry Code: 424193
In addition to the Company releasing its 4th Quarter and Year End earnings the Company will discuss:
The Company’s execution of its ongoing digital strategy.
The Company’s ongoing efforts to evaluate non-core asset sales and the use of such proceeds for buybacks, dividends and other corporate purposes.
The Company’s plans to refresh the board.
The Company’s continuing evaluation of market and corporate level expenses to be in line with the Company’s operating verticals.
The Company requests that all parties that have a question that they would like to submit to the Company to please email the inquiry by 10:00 a.m. EST on March 11, 2025, to SagaIR@sagacom.com. The Company will discuss, during the limited period of the conference call, those inquiries it deems of general relevance and interest. Only inquiries made in compliance with the foregoing will be discussed during the call.
Saga’s earnings release will contain certain non-GAAP financial measures including station operating income, trailing 12-month consolidated EBITDA, and same station financial information. A reconciliation of all non-GAAP financial measures to the most directly comparable GAAP measures will be provided in the earnings release.
Saga is a media company whose business is devoted to acquiring, developing, and operating broadcast properties with a growing focus on opportunities complimentary to our core radio business including digital, e-commerce and non-traditional revenue initiatives. Saga owns or operates broadcast properties in 28 markets, including 82 FM and 31 AM radio stations and 79 metro signals. For additional information, contact us at (313) 886-7070 or visit our website at www.sagacom.com.
Key Points: – US manufacturing PMI dipped to 50.3 in February, signaling continued but slowing growth. – Concerns over new tariffs on imports from Canada, Mexico, and China are creating uncertainty for manufacturers. – Prices for raw materials surged to their highest levels since June 2022, potentially impacting production costs.
The US manufacturing sector remained stable in February, though concerns over looming tariffs threatened to disrupt recent gains. While the Institute for Supply Management (ISM) Manufacturing Purchasing Managers’ Index (PMI) registered at 50.3—just above the threshold for expansion—key indicators such as new orders and employment showed signs of weakness.
The report indicated that while the manufacturing industry is maintaining momentum, companies are growing increasingly uneasy about potential tariffs on goods imported from Canada, Mexico, and China. The uncertainty surrounding these trade policies has led to a slowdown in new orders, as customers hesitate to commit to long-term contracts.
Tariffs Fuel Uncertainty and Price Increases Manufacturers reported that trade tensions and prospective retaliatory measures from key US partners were affecting business sentiment. Firms in the chemical and transportation equipment industries, in particular, noted disruptions caused by a lack of clear guidance on tariff implementation. The uncertainty has also impacted investment decisions, with businesses pausing expansion plans.
At the same time, prices for manufacturing inputs surged to their highest levels since June 2022. The ISM’s price index jumped to 62.4 from 54.9 in January, reflecting the growing cost of raw materials. Many manufacturers are concerned that rising costs will eventually be passed on to consumers, potentially reversing recent efforts to stabilize inflation.
Employment and Supply Chain Challenges Employment in the sector contracted after briefly expanding in January. The manufacturing employment index fell to 47.6, suggesting that firms are pulling back on hiring in response to economic uncertainty. With weaker demand and higher costs, companies are taking a cautious approach to workforce expansion.
Supply chains, which had been recovering from disruptions in previous years, also showed signs of strain. The ISM supplier deliveries index increased to 54.5, indicating longer wait times for materials. This is typically a sign of strong demand, but in this case, it reflects supply chain bottlenecks and manufacturers front-loading inventory in anticipation of potential tariff impacts.
Looking Ahead With the Trump administration expected to finalize tariff decisions in the coming days, manufacturers remain on edge. Industries reliant on imported steel, aluminum, and electronic components could face the greatest challenges, particularly as suppliers adjust pricing in response to trade policy changes.
The ISM report follows a series of economic data releases that suggest the US economy may have lost momentum in early 2025. Weak consumer spending, a widening goods trade deficit, and a decline in homebuilding all point to a more cautious economic outlook. Some economists now believe that GDP could contract in the first quarter.
As the manufacturing sector braces for potential headwinds, all eyes remain on the White House’s next moves regarding tariffs. The coming weeks will be critical in determining whether February’s stability can be sustained or if rising costs and trade uncertainty will trigger a broader slowdown.
Mr. Long’s Proven Track Record in Driving E-Commerce Growth and Innovation Includes Leadership Roles at Walmart, Ashley Furniture, and Amazon
Mr. Long will Collaborate with the Existing E-commerce Management Team and Founders to Expand SKYX ‘s Sales and Market Penetration of Its Disruptive Advance and Smart Home Plug & Play Technologies in the U.S. and Canadian Markets
MIAMI, March 03, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive advanced and smart home platform technology company for homes and buildings, with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and home décor websites, announces today that Huey Long, former Director of Amazon E-Commerce, Senior Vice President of Walmart, and Executive Vice President at Ashley Furniture, has joined SKYX to lead its e-commerce platform.
Mr. Long will work together with the existing e-commerce management team and founders to drive innovation and expand sales and market penetration of SKYX’s advanced and smart home plug & play technologies across the U.S. and Canadian markets.
Long is renowned for his strategic vision and operational excellence across advanced business ecosystems. With over 28 years of experience in e-commerce, omnichannel retail, and global sourcing, he brings a wealth of expertise and leadership to SKYX. His career includes pivotal roles at industry-leading companies, including as Director at Amazon.com, where he spearheaded the development of Amazon Basics, the company’s first private brand initiative. Additionally, he has served as Senior Vice President at Walmart Stores Inc., General Merchandise Manager at Sam’s Club, and Executive Vice President at Ashley Furniture.
Commenting on his appointment, Huey Long said, “I am honored to join SKYX and work with its e-commerce management team and founders at such an exciting time. The company’s commitment to innovation with its game-changing plug & play technologies aligns perfectly with my passion for driving value through innovation, strategic transformation, and operational excellence. I look forward to driving growth and further expanding the market penetration of SKYX’s technologies in the U.S. and Canadian markets. SKYX’s disruptive and smart platform technologies present a unique opportunity for recurring revenues.”
Rani Kohen, Founder/Inventor and Executive Chairman, of SKYX Platforms, said, “Huey’s extensive experience in e-commerce and omnichannel retail makes him uniquely positioned to drive the next phase of growth of our advanced and smart home plug & play platform technologies. We are excited to have Huey on board and look forward to his leadership as we continue to grow our market penetration.”
About SKYX Platforms Corp.
As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 97 U.S. and global patents and patent pending applications. Additionally, the Company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn.
Forward-Looking Statements Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.
ATLANTA, GA – March 3, 2025 – GeoVax Labs, Inc. (Nasdaq: GOVX), a leader in developing vaccines and immunotherapies for infectious diseases and cancer, underscores the strategic importance of its Modified Vaccinia Ankara (MVA) vaccine platform in helping to bolster U.S. biodefense capabilities. Efforts in MVA vaccine design and manufacturing improvements align with key recommendations from the recent “Bolstering U.S. Biodefense: Recommendations For The New Administration” report, published by the Janne E. Nolan Center on Strategic Weapons at the Council on Strategic Risks, a respected think tank specializing in national security and biodefense policy. The report emphasizes the need for robust, diversified medical countermeasures to protect national and global security.
Addressing Biodefense Gaps with MVA-Based Solutions
The “Bolstering U.S. Biodefense” report highlights the urgency of strengthening U.S. preparedness against biological threats, including deliberate attacks, emerging infectious diseases, and supply chain vulnerabilities. GeoVax’s efforts towards the development of MVA-based vaccines, including GEO-MVA for vaccination against Mpox and smallpox, and efforts to transition to a next-generation manufacturing platform utilizing a continuous avian cell line, directly align with these national security objectives:
Vaccine Supply Chain Resilience: Current reliance on a single non-U.S. manufacturer for critical vaccines, such as MVA, poses a national security risk. GeoVax’s efforts to transition to a next generation manufacturing platform should allow for the use of existing domestic manufacturing facilities, leading to a reduced dependence on foreign suppliers and enhancing supply chain security.
Advanced Biomanufacturing for Scalability: The biodefense report calls for investment in next-generation biomanufacturing. GeoVax is developing a continuous cell line-based MVA manufacturing platform that it expects will result in rapid, high-volume vaccine production, which is currently not feasible utilizing existing MVA directed manufacturing platforms
Diverse Medical Countermeasures for Threat Readiness: The Department of Defense’s Biodefense Posture Review and National Biodefense Strategy emphasize the need for multiple vaccine approaches. GeoVax’s MVA platform complements mRNA and protein-based vaccines, ensuring a broader and more resilient national preparedness framework.
Strategic National Stockpile Shortfalls: The 2022 Mpox epidemic revealed significant vaccine shortages in the National Strategic Stockpile, leaving public health officials unable to meet urgent demand. The reliance on a single foreign supplier for any vaccine can further exacerbate these challenges, reinforcing the need for a diversified, U.S.-based vaccine supply.
Relevance to the New HHS Administration
The transition of leadership at the U.S. Department of Health and Human Services (HHS) presents a pivotal moment for vaccine policy and national preparedness. The Administration has emphasized transparency, safety, and domestic vaccine manufacturing, aligning closely with GeoVax’s mission.
Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring America’s self-sufficiency in pandemic preparedness.
Advancing a Diversified Vaccine Portfolio: With a growing consensus that a single vaccine platform is unable to address the breadth of infectious disease concerns, there is a clear recognition of the benefits of having multiple alternative vaccine platforms available. GeoVax’s MVA-based approach provides a proven, durable, and safe alternative, reinforcing a well-rounded immunization strategy.
Public Trust and Transparency: Given the call for increased scrutiny of vaccine development, GeoVax is committed to transparency, publishing full clinical trial results and working collaboratively with HHS to foster public confidence.
Policy Action to Strengthen U.S. Biodefense
GeoVax urges policymakers to act swiftly in supporting domestic vaccine production and biodefense innovation. Key recommendations include:
Expanding Federal Investment in MVA-Based Vaccines: Increased funding from BARDA, the Department of Defense, and the NIH to accelerate the development, next-generation manufacturing scale up and deployment of GEO-MVA.
Accelerating Regulatory Approvals: Streamlined pathways for emergency use authorization and priority review of MVA-based vaccines to strengthen national preparedness.
Public-Private Partnerships: Enhanced collaboration between government agencies, biotechnology firms, and global health organizations to integrate MVA-based solutions into pandemic and biodefense planning.
A Call for Action
“The ‘Bolstering U.S. Biodefense’ report clearly articulates the vulnerabilities in our national health security framework. GeoVax is committed to helping address these gaps with our MVA-based vaccines and next-generation manufacturing capabilities,” said David Dodd, Chairman & CEO of GeoVax. “With a new HHS administration, there is a timely opportunity to strengthen domestic vaccine infrastructure and ensure greater national resilience against emerging threats.”
GeoVax remains dedicated to advancing innovative, scalable, and accessible vaccine solutions to safeguard public health and national security.
References: Council on Strategic Risks. (2025). Bolstering U.S. Biodefense: Strengthening the Nation’s Response to Biological Threats. Janne E. Nolan Center on Strategic Weapons. Retrieved from https://www.councilonstrategicrisks.org.
About GeoVax
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin® combined with an immune checkpoint inhibitor is planned. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.
Forward-Looking Statements
This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control.
Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
New partnership reaffirms ODP Business Solutions’ commitment to the hospitality industry and adjacent categories, fostering a refined guest experience
BOCA RATON, Fla.–(BUSINESS WIRE)–Mar. 3, 2025– ODP Business Solutions, a leading supplier of workplace solutions and services and a division of The ODP Corporation (NASDAQ: ODP), announced today a strategic distribution partnership with Hunter Amenities. ODP Business Solutions will distribute Hunter’s wide range of hotel and guest amenities to hospitality partners, including liquid beauty products, soaps, dry goods and more, all uniquely bundled to accommodate the needs of every client and guest.
“Our partnership with Hunter Amenities demonstrates our commitment to continuing to expand our presence and product offerings in the hospitality industry and other adjacent sectors,” said David Centrella, EVP and president of ODP Business Solutions. “Distributing Hunter Amenities’ premium products further positions ODP Business Solutions to serve as a key-supplier for in-room needs.”
Hunter Amenities is an award-winning global manufacturing company that has been a pioneer in the personal care and hospitality industry for more than four decades. Renowned for its world-class manufacturing facilities that combine artisanal traditions with cutting-edge innovation, the company partners with some of the world’s most prestigious hospitality and retail brands. Hunter Amenities now provides its rich portfolio of high-end personal care products through ODP Business Solutions’ vast network of solutions and service, advancing how the hospitality industry can bring a luxurious, elevated experience to their guests.
“Partnering with ODP Business Solutions as a distribution partner is a natural fit for our company. Their best-in-class distribution capabilities and remarkably agile team give us complete confidence, which is why we’ve gone all in—rolling out our full portfolio within their expansive customer network. This collaboration is a true win-win for both organizations and a game-changer for the entire hospitality industry,” said John Hunter, founder of Hunter Amenities.
Hunter’s extensive product portfolio includes curated shampoo, conditioner, body wash, lotion, and hand wash, along with VIP indulgences such as lip balm, hand cream, eye cream, sleep balm, facial mist, and pillow mist—crafted for discerning travelers who expect nothing but the best.
“Introducing Hunter Amenities to our hospitality distribution services will provide our customers the opportunity to enhance each guest’s stay with custom, high-end offerings that pair seamlessly with ODP Business Solutions’ unparalleled service,” said Nisha Brown, vice president of marketing & product management at ODP Business Solutions. “Hunter is a globally recognized luxury brand that aligns perfectly with our commitment to quality and innovation. We look forward to continuing our growth in the hospitality market and beyond, offering tailored solutions that meet the evolving needs of our clients.”
ODP Business Solutions also delivers high-quality solutions in categories that include technology, professional cleaning and furniture, while expanding into new verticals to better serve the needs of its customers. This partnership announcement follows ODP Business Solutions recent milestone contract with a leading hospitality management company.
To learn more about ODP Business Solutions, visit odpbusiness.com.
About ODP Business Solutions:
ODP Business Solutions is a trusted partner with more than 30 years of experience working with businesses to adapt to the ever-changing world of work. From technology transformation, sustainability, innovative workspace design, cleaning and breakroom, and everything in between, ODP Business Solutions has the integrated products and services businesses need. Powered by a collaborative team of experienced business consultants, world-class logistics and trusted brand names, ODP Business Solutions advances how the working world gets work done. For more information on ODP Business Solutions, visit odpbusiness.com.
ODP Business Solutions is a division of The ODP Corporation (NASDAQ: ODP). ODP and ODP Business Solutions are trademarks of ODP Business Solutions, LLC. Any other product or company names mentioned herein are the trademarks of their respective owners.
About Hunter Amenities:
Since 1981, Hunter Amenities has become one of the world’s largest manufacturers and leading formulators of superior personal care guest amenities, servicing hospitality customers in over 100 countries. Our products range from a prominent selection of licensed, internationally recognized designer and cosmetic brands to distinctive luxurious spa hotel amenities and retail collections.
The ODP Corporation (NASDAQ:ODP) is a leading provider of products and services through an integrated business-to-business (B2B) distribution platform and omnichannel presence, which includes world-class supply chain and distribution operations, dedicated sales professionals, online presence and a network of Office Depot and OfficeMax retail stores. Through its operating companies Office Depot, LLC; ODP Business Solutions, LLC; and Veyer, LLC, The ODP Corporation empowers every business, professional, and consumer to achieve more every day. For more information, visit theodpcorp.com.
This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements or disclosures may discuss goals, intentions and expectations as to future trends, plans, events, results of operations, cash flow or financial condition, or state other information relating to, among other things, The ODP Corporation (“the Company”), based on current beliefs and assumptions made by, and information currently available to, management. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “expectations”, “outlook,” “intend,” “may,” “possible,” “potential,” “predict,” “project,” “propose” “aim” or other similar words, phrases or expressions, or other variations of such words. These forward-looking statements are subject to various risks and uncertainties, many of which are outside of the Company’s control. There can be no assurances that the Company will realize these expectations or that these beliefs will prove correct, and therefore investors and stakeholders should not place undue reliance on such statements.
Investors and shareholders should carefully consider the foregoing factors and the other risks and uncertainties described in the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission. The Company does not assume any obligation to update or revise any forward-looking statements.
MALVERN, Pa., March 03, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the European Commission has provided a positive opinion from the European Medicines Agency’s (EMA) Committee for Advanced Therapies (CAT) for OCU410 and OCU410ST Advanced Therapy Medicinal Product (ATMP) classification. OCU410 is a novel, multifunctional modifier gene therapy candidate being developed for the treatment of patients with vision loss due to geographic atrophy (GA)—an advanced stage of dry age-related macular degeneration (dAMD)—and OCU410ST is being developed for Stargardt disease due to ABCA4-related retinopathies.
GA affects 2-3 million people in the United States (U.S.) and Europe combined. There are two approved therapies in the U.S. that require frequent dosing (every month or every other month), however neither therapy has been approved in Europe. Stargardt disease affects 100,000 people in the U.S. and Europe combined, and there are no approved treatments available globally.
“Receiving ATMP classification for OCU410 and OCU410ST is a critical step to potentially address these severely unmet medical needs in the very near future,” said Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen. “Dosing of Phase 2 in the ongoing OCU410 ArMaDa clinical trial is complete, and we are on track to initiate the Phase 3 clinical trial next year to pursue potential Marketing Authorization Application (MAA) and Biologics License Application (BLA) filings in 2028. Last week, the U.S. Food and Drug Administration (FDA) endorsed Ocugen’s plan to move forward with a Phase 2/3 pivotal confirmatory clinical trial for OCU410ST, which can be the basis of BLA and potential MAA submissions in 2027.”
ATMP classification is granted to medicines that can offer groundbreaking opportunities for the treatment of disease and accelerates the regulatory review timeline of this potential one-time gene therapy for life. Additionally, this classification allows Ocugen to interact with EMA more frequently for scientific advice and protocol assistance.
Preliminary 9-month data of OCU410 in GA patients demonstrated considerably slower lesion growth (44%) from baseline and clinically meaningful 2-line (10-letter) improvement in visual function (LLVA) in treated eyes compared to untreated eyes in the Phase 1 portion of the trial. Furthermore, a single subretinal OCU410 treatment preserves more retinal tissue around GA lesions of treated eyes at 9 months compared to published data on currently available GA therapies.
6-month data from Phase 1 of the OCU410ST GARDian clinical trial demonstrated considerably slower lesion growth (52%) from baseline in treated eyes versus untreated fellow eyes and clinically meaningful 2-line (10-letter) improvement in visual function (BCVA), which is statistically significant (p=0.02) in treated eyes. The Company plans to initiate the Phase 2/3 pivotal confirmatory clinical trial for OCU410ST by mid-2025.
“The novel modifier gene in OCU410 and OCU410ST targets all four pathways linked with dAMD and Stargardt and is delivered through a single subretinal injection as a one-and-done treatment,” said Dr. Huma Qamar, Chief Medical Officer at Ocugen. “We are very pleased with the structural and functional outcomes demonstrated by both of these candidates, along with a stellar safety profile.”
OCU410 and OCU410ST utilize an adeno-associated virus (AAV) platform for the retinal delivery of the RORA (ROR Related Orphan Receptor A) gene. The RORA protein plays an important role in lipid metabolism, reducing lipofuscin deposits and oxidative stress, and demonstrates an anti-inflammatory role as well as inhibiting the complement system in both in vitro and in vivo (animal model) studies.
About Ocugen, Inc. Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at www.ocugen.com and follow us on X and LinkedIn.
Cautionary Note on Forward-Looking Statements
Thispressreleasecontainsforward-lookingstatementswithinthemeaningofThePrivateSecuritiesLitigationReformActof1995,including,butnot limited to, statements regarding qualitative assessments of available data, potential benefits, expectations for ongoing clinical trials, anticipated regulatory filings and anticipated development timelines,whicharesubjecttorisksanduncertainties.Wemay,insomecases,usetermssuchas “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations, including,butnotlimitedto,therisksthatpreliminary,interimandtop-lineclinicaltrialresultsmaynotbeindicativeof,andmaydifferfrom,finalclinical data;the ability of OCU410 and OCU410ST to perform in humans in a manner consistent with nonclinical, preclinical or previous clinical study data;thatunfavorablenewclinicaltrialdatamayemergeinongoingclinicaltrialsorthroughfurtheranalysesofexistingclinicaltrialdata;thatearlier non-clinicalandclinicaldataandtestingofmaynotbepredictiveoftheresultsorsuccessoflaterclinicaltrials;andthatthatclinicaltrialdataare subject to differing interpretations and assessments, including by regulatory authorities.Theseandotherrisksanduncertaintiesaremorefully describedinourperiodicfilingswiththeSecuritiesandExchangeCommission(SEC),includingtheriskfactorsdescribedinthesectionentitled“Risk Factors”inthequarterlyandannualreportsthatwefilewiththeSEC.Anyforward-lookingstatementsthatwemakeinthispressreleasespeakonlyas ofthedateofthispressrelease.Exceptasrequiredbylaw,weassumenoobligationtoupdateforward-lookingstatementscontainedinthispress release whether as a result of new information, future events, or otherwise, after the date of this press release.
CALGARY AB, March. 3, 2025 /CNW/ – InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) (“InPlay” or the “Company”) is pleased to confirm that its Board of Directors has declared a monthly cash dividend of $0.015 per common share payable on March 31, 2025, to shareholders of record at the close of business on March 14, 2025. The monthly cash dividend is expected to be designated as an “eligible dividend” for Canadian federal and provincial income tax purposes.
About InPlay Oil Corp.
InPlay is a junior oil and gas exploration and production company with operations in Alberta focused on light oil production. The company operates long-lived, low-decline properties with drilling development and enhanced oil recovery potential as well as undeveloped lands with exploration possibilities. The common shares of InPlay trade on the Toronto Stock Exchange under the symbol IPO and the OTCQX Exchange under the symbol IPOOF.
For further information please contact: Doug Bartole, President and Chief Executive Officer, InPlay Oil Corp., Telephone: (587) 955-0632; Darren Dittmer, Chief Financial Officer, InPlay Oil Corp., Telephone: (587) 955-0634
FORT WORTH, Texas, March 3, 2025 /PRNewswire/ — AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions in North America, today announced the completion of repricing its $400 million Senior Secured Revolving Line of Credit. The repricing decreased the interest rate margin applicable to the Revolving Credit Loans from margins ranging from 275 basis points to 350 basis points (subject to leverage ratio step-downs) to margins ranging from 175 basis points to 275 basis points (subject to leverage ratio step-downs); (b) reduced the Commitment Fee applicable to the Revolving Credit Loans from fees ranging from 25 basis points to 37.5 basis points (subject to leverage ratio step-downs) to fees ranging from 20 basis points to 30 basis points (subject to leverage ratio step-downs); and (c) reduced the Letter of Credit Fees from 425 basis points to fees ranging from 175 basis points to 275 basis points (subject to leverage ratio step-downs).
Jason Crawford, Chief Financial Officer commented, “We are pleased to announce the successful completion of our revolver repricing. The repricing will result in significantly lower interest costs through the maturity of the facility and demonstrates our ongoing commitment to interest expense reduction.”
About AZZ Inc. AZZ Inc. is the leading independent provider of hot-dip galvanizing and coil coating solutions to a broad range of end-markets. Collectively, our business segments provide sustainable, unmatched metal coating solutions that enhance the longevity and appearance of buildings, products and infrastructure that are essential to everyday life.
Safe Harbor Statement Certain statements herein about our expectations of future events or results constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by terminology such as “may,” “could,” “should,” “expects,” “plans,” “will,” “might,” “would,” “projects,” “currently,” “intends,” “outlook,” “forecasts,” “targets,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Such forward-looking statements are based on currently available competitive, financial, and economic data and management’s views and assumptions regarding future events. Such forward-looking statements are inherently uncertain, and investors must recognize that actual results may differ from those expressed or implied in the forward-looking statements. Forward-looking statements speak only as of the date they are made and are subject to risks that could cause them to differ materially from actual results. Certain factors could affect the outcome of the matters described herein. This press release may contain forward-looking statements that involve risks and uncertainties including, but not limited to, changes in customer demand for our products and solutions, including demand by the construction markets, the industrial markets, and the metal coatings markets. We could also experience additional increases in labor costs, components and raw materials including zinc and natural gas, which are used in our hot-dip galvanizing process; supply-chain vendor delays; customer requested delays of our products or solutions; delays in additional acquisition opportunities; an increase in our debt leverage and/or interest rates on our debt, of which a significant portion is tied to variable interest rates; availability of experienced management and employees to implement AZZ’s growth strategy; a downturn in market conditions in any industry relating to the products we inventory or sell or the solutions that we provide; economic volatility, including a prolonged economic downturn or macroeconomic conditions such as inflation or changes in the political stability in the United States and other foreign markets in which we operate; acts of war or terrorism inside the United States or abroad; and other changes in economic and financial conditions. AZZ has provided additional information regarding risks associated with the business, including in Part I, Item 1A. Risk Factors, in AZZ’s Annual Report on Form 10-K for the fiscal year ended February 29, 2024, and other filings with the SEC, available for viewing on AZZ’s website at www.azz.com and on the SEC’s website at www.sec.gov. You are urged to consider these factors carefully when evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. These statements are based on information as of the date hereof and AZZ assumes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
Investor Relations and Company Contact: David Nark, Senior Vice President of Marketing, Communications, and Investor Relations AZZ Inc. (817) 810-0095 www.azz.com
Investor Contact: Sandy Martin / Phillip Kupper Three Part Advisors (214) 616-2207 www.threepa.com
